[PDF] “ ”

Page 1. Johnson & Johnson 2004 Annual Report “ W e believe our first responsibility is to the doctors, nurses and patients, to ... www.investor.jnj.com/common/download/download.cfm?companyid=JNJ&fileid=180976&filekey=7D4602...

[PDF] Annual Report

Page 1. 2003 Annual Report J oh ns on & J oh n son 2003 A nnu al R ep or t Page 2. Net Sales (in billions of dollars) About the Company ... www.investor.jnj.com/common/download/download.cfm?companyid=JNJ&fileid=180977&filekey=C0E897...

[PDF] Annual Report

Page 1. 2002 Annual Report Page 2. Description of the Company Johnson & Johnson has $36.3 billion in sales and is the world’s most ... www.investor.jnj.com/common/download/download.cfm?companyid=JNJ&fileid=180981&filekey=674ABA...

[PDF] Reaching more Serving more health

Page 1. 2005 Annual Report JOHNSON & JOHNSON 2005 ANNU AL REPORT Reaching more people Serving more health needs Page 2. TABLE OF CONTENTS ... www.investor.jnj.com/common/download/download.cfm?companyid=JNJ&fileid=180971&filekey=6D92BC...

EMEA Approves Update to Velcade® (bortezomib) Label to Include ...

... Prezista® & Intelence® (HIV), Stelara (psoriasis), Topamax® (epilepsy, migraine), Doribax® (antibiotics), Daktarin® (anti-fungal), Sporanox (anti-fungal ... www.jnj.com/connect/news/all/EMEA-approves-update-to-Velcade-bortezomib-label-to-include-survival-be... - 36k

Ortho Biotech Oncology Research & Development Data to Be Presented ...

... Prezista® & Intelence® (HIV), Stelara® (psoriasis), Topamax® (epilepsy, migraine), Doribax® (antibiotics), Daktarin® (anti-fungal), Sporanox (anti-fungal ... www.jnj.com/connect/news/all/20091204_090000 - 38k

[PDF] Reaching more Serving more health

Page 1. 2005 Annual Report JOHNSON & JOHNSON 2005 ANNU AL REPORT Reaching more people Serving more health needs Page 2. TABLE OF CONTENTS ... www.investor.jnj.com/common/download/download.cfm?companyid=JNJ&fileid=180971&filekey=6d92bc...

[PDF] Annual Report

Page 1. 2003 Annual Report J oh ns on & J oh n son 2003 A nnu al R ep or t Page 2. Net Sales (in billions of dollars) About the Company ... www.investor.jnj.com/common/download/download.cfm?companyid=JNJ&fileid=180977&filekey=c0e897...

[PDF] “ ”

Page 1. Johnson & Johnson 2004 Annual Report “ W e believe our first responsibility is to the doctors, nurses and patients, to ... www.investor.jnj.com/common/download/download.cfm?companyid=JNJ&fileid=180976&filekey=7d4602...

[PDF] JOHNSON & JOHNSON

... and recently approved for use in the prevention of migraines; REMICADE, a treatment for rheumatoid arthritis and Crohn's disease; SPORANOX, an antifungal ... www.investor.jnj.com/common/download/sec.cfm?companyid=JNJ&fid=200406-04-132&cik=200406

[PDF] JOHNSON & JOHNSON

... transdermal system), a transdermal patch for chronic pain; ULTRACET (acetaminophen/ tramadol hydrochloride), an analgesic, and SPORANOX (itraconazole), an ... www.investor.jnj.com/common/download/sec.cfm?companyid=JNJ&fid=200406-05-131&cik=200406

[PDF] JOHNSON & JOHNSON

... Sales results for DURAGESIC, a transdermal patch for chronic pain; ULTRACET, an analgesic; and SPORANOX, an antifungal, were all negatively impacted by generic ... www.investor.jnj.com/common/download/sec.cfm?companyid=JNJ&fid=200406-06-80&cik=200406

[PDF] UNITED STATES

Page 1. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (X) Quarterly Report Pursuant to Section ... www.investor.jnj.com/common/download/sec.cfm?companyid=JNJ&fid=200406-03-54&cik=200406

[PDF] JOHNSON & JOHNSON

Page 1. FORM 8-K JOHNSON & JOHNSON (Unscheduled Material Events) Filed 3/1/2004 For Period Ending 3/1/2004 Address ONE JOHNSON & JOHNSON PLZ ... www.investor.jnj.com/common/download/sec.cfm?companyid=JNJ&fid=200406-04-49&cik=200406

[PDF] JOHNSON & JOHNSON

Page 1. FORM 10-Q JOHNSON & JOHNSON (Quarterly Report) Filed 11/3/2004 For Period Ending 9/26/2004 Address ONE JOHNSON & JOHNSON PLZ ... www.investor.jnj.com/common/download/sec.cfm?companyid=JNJ&fid=200406-04-134&cik=200406

[PDF] JOHNSON & JOHNSON

Page 1. FORM 10-Q JOHNSON & JOHNSON (Quarterly Report) Filed 5/5/2004 For Period Ending 3/28/2004 Address ONE JOHNSON & JOHNSON PLZ ... www.investor.jnj.com/common/download/sec.cfm?companyid=JNJ&fid=200406-04-81&cik=200406

[PDF] JOHNSON & JOHNSON

Page 1. FORM 10-K JOHNSON & JOHNSON (Annual Report) Filed 3/11/2004 For Period Ending 12/28/2003 Address ONE JOHNSON & JOHNSON PLZ ... www.investor.jnj.com/common/download/sec.cfm?companyid=JNJ&fid=950123-04-3155&cik=200406

[PDF] JOHNSON & JOHNSON

... fentanyl transdermal system), a transdermal patch for chronic pain; ULTRACET(r) (acetaminophen/tramadol hydrochloride), an analgesic; SPORANOX(r) (itraconazole ... www.investor.jnj.com/common/download/sec.cfm?companyid=JNJ&fid=200406-06-10&cik=200406

[PDF] JOHNSON & JOHNSON

Page 1. FORM 10-Q JOHNSON & JOHNSON (Quarterly Report) Filed 8/10/2005 For Period Ending 7/3/2005 Address ONE JOHNSON & JOHNSON PLZ ... www.investor.jnj.com/common/download/sec.cfm?companyid=JNJ&fid=200406-05-106&cik=200406

[PDF] JOHNSON & JOHNSON

Page 1. FORM 10-Q JOHNSON & JOHNSON (Quarterly Report) Filed 11/8/2006 For Period Ending 10/1/2006 Address ONE JOHNSON & JOHNSON PLZ ... www.investor.jnj.com/common/download/sec.cfm?companyid=JNJ&fid=200406-06-138&cik=200406

Refine Your Search